Perinatal development influences mechanisms of bradykinin-induced relaxations in pulmonary resistance and conduit arteries differently

Citations of this article
Mendeley users who have this article in their library.


Objective: As bradykinin (BYK) relaxes conduit (EPA) and resistance (RPA) pulmonary arteries from both perinatal and adult lungs, we investigated whether this vasodilator's relaxation-mechanisms were altered during perinatal development, differed between EPA and RPA and differed with other endothelium-dependent vasodilators, acetyicholine (ACH) and substance P (SP). Methods: Arteries from mature foetal (5 days), neonatal (≈5 min), newborn (60-84 h) and adult pigs (≥6 months) were isolated, mounted for in vitro isometric force recording, activated with PGF2α (30 μmol/l) and relaxed with BYK (10 pmol/l-1 μmol/l), SP (10 pmol/l-0.1 μmol/l) or ACH (1 nmol/l-1 mmol/l). Results: (i) BYK: L-NAME (100 μmol/l) attenuated relaxations in foetal EPA (≈55%) but nearly abolished them in the adult (≈80%). In RPA, L-NAME nearly abolished (≈90%) relaxations in the foetus and this effect diminished progressively with age to ≈20% in the adult. Indomethacin (IND, μmol/l) attenuated relaxations in neonatal (≈25%), new-born and adult EPA (both ≈45%). Together, L-NAME and IND abolished relaxations in all EPA and in neonatal RPA but not in older RPA. SKF525a (100 μmol/l) attenuated relaxations in foetal RPA (≈4%), diminishing in the adult RPA to ≈10%. Together, SKF52Sa and L-NAME largely abolished relaxations in postnatal RPA (≈80%). Activation with K+=125 mmol/l attenuated relaxations in adult EPA (≈80%), foetal RPA (≈45%) and neonatal RPA (≈75%) and abolished relaxations in RPA from older ages. (ii) ACH: L-NAME abolished relaxations in new-born EPA and RPA. In adult EPA, combined L-NAME and IND moderately attenuated relaxations. (iii) SP: Combined application of L-NAME and IND attenuated relaxations to a similar degree in new-born and adult EPA and RPA. Conclusions: In postnatal EPA, BYK-relaxations depend completely on prostaglandin- and NO-synthesis whereas those to SP (at all ages) and ACH (in the adult) do not. In RPA, BYK-relaxations develop from being completely dependant on the sole release of NO (foetus) to being almost completely independent of it (adult), a situation mimicked partially by SP but not by ACH, which, in new-born RPA is completely dependent on NO. BYK-relaxations in postnatal RPA depend on the release of a hyperpolarising factor generated through an SKF525a-sensitive pathway in conjunction with NO. The mechanisms of endothelium-dependent BYK-relaxations in the pulmonary vascular bed undergo diverging alterations, depending on the stage of development and arterial size/function. These changes are specific for BYK as they differ from those obtained from ACH or SP. © 2001 Elsevier Science B.V.




Boels, P. J., Deutsch, J., Gao, B., & Haworth, S. G. (2001). Perinatal development influences mechanisms of bradykinin-induced relaxations in pulmonary resistance and conduit arteries differently. Cardiovascular Research, 51(1), 140–150.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free